(Q46752526)

English

The Nuclear Factor kappaB Inhibitor Pyrrolidine Dithiocarbamate Prevents Cardiac Remodelling and Matrix Metalloproteinase-2 Up-Regulation in Renovascular Hypertension

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/25816715

The Nuclear Factor kappaB Inhibitor Pyrrolidine Dithiocarbamate Prevents Cardiac Remodelling and Matrix Metalloproteinase-2 Up-Regulation in Renovascular Hypertension (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/25816715

Stefany B A Cau

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25816715%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25816715%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Danielle A Guimaraes

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25816715%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Elen Rizzi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25816715%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Raquel F Gerlach

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25816715%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Jose E Tanus-Santos

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25816715%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

28 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/25816715

Basic and Clinical Pharmacology and Toxicology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25816715%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

117

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25816715%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25816715%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

234-241

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25816715%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Left ventricular hypertrophy: pathogenesis, detection, and prognosis

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

The progression from hypertension to congestive heart failure

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

The progression of hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Progress in matrix metalloproteinase research

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Inhibition of nuclear factor κB regresses cardiac hypertrophy by modulating the expression of extracellular matrix and adhesion molecules

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Tempol inhibits TGF-β and MMPs upregulation and prevents cardiac hypertensive changes

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Alteration of local ACE activity and vascular responsiveness during development of 2K1C renovascular hypertension

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Pre-clinical safety evaluation of pyrrolidine dithiocarbamate.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Nuclear factor-kappaB signaling contributes to severe, but not moderate, angiotensin II-induced left ventricular remodeling

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Suppression of the development of hypertension by the inhibitor of inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolism.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Thiol antioxidant reversal of pyrrolidine dithiocarbamate-induced reciprocal regulation of AP-1 and NF-kappaB.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Inhibition of NF-kappaB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Perinatal inhibition of NF-kappaB has long-term antihypertensive effects in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Nuclear factor kappa B and matrix metalloproteinase induced receptor cleavage in the spontaneously hypertensive rat.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Matrix Metalloproteinase Inhibition Improves Cardiac Dysfunction and Remodeling in 2-Kidney, 1-Clip Hypertension

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Intracellular Action of Matrix Metalloproteinase-2 Accounts for Acute Myocardial Ischemia and Reperfusion Injury

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Matrix metalloproteinase-2 degrades the cytoskeletal protein α-actinin in peroxynitrite mediated myocardial injury

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12400

21 January 2018

Identifiers

10.1111/BCPT.12400

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25816715%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25816715%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46752526&oldid=2129853547"